Drug
IDP-122 Lotion
IDP-122 Lotion is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
100%(3 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_3
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
NCT03987763
completedphase_2
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
NCT02785185
completedphase_3
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02514577
completedphase_3
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02515097
Clinical Trials (4)
Showing 4 of 4 trials
NCT03987763Phase 4
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
NCT02785185Phase 2
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
NCT02514577Phase 3
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02515097Phase 3
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4